Screening for abnormalities of the Protein C Anticoagulant Pathway using the Protein C Pathway Test

Fibrinolysis and Proteolysis

Volumn 13, Issue SUPPL. 1, 1999, Pages 21-25

  Toulon, P ^a   Perez, P ^a   Demay, Y ^a   Dornon, O ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; PROTEIN C; PROTEIN S;

ADULT; AGED; ANTICOAGULATION; BLOOD CLOTTING TIME; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; SCREENING TEST; THROMBOPHILIA;

EID: 0033001258     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. De Stefane V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-3544.
2. Lane DA. Mannucci PM, Bauer KA. et al. Inherited thrombophilia. Part 1. Thromb Haemost 1996; 76: 651662.
3. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia. Part 2. Thromb Haemost 1996; 76: 824834.
4. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sei USA 1993; 90: 1004-1008.
5. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
6. Duchemin J, Pittet JL, Tartary M. et al. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma. Thromb Haemost 1994; 71: 331-338.
7. Kraus M, Noah M, Fickenscher K. The PCAT- a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res 1995; 79: 217-222.
8. Denson KWE, Haddon ME, Reed SV, Davidson S, Littlewood TJ. A more discriminating test for APC resistance and a possible screening test to include protein C and protein S. Thromb Res 1996; 81: 151-156.
9. Robert A, Eschwege V, Hameg H, Drouet L, Aillaud MF. Anticoagulant response to Agkistrodon Contortrix Venom (ACV) test: a new global test to screen for defects in the anticoagulant protein C pathway. Thromb Haemost 1996; 75: 562-566.
10. Preda L, Simioni P, Legnani C, et al. A new global test for the evaluation of the protein C-protein S system. Blood Coag Fibrinol 1996; 7: 465-469.
11. Gable PS, Le DT, McGehee W, Rapaport SI. A Protacbased screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathway. Blood Coag Fibrinolysis 1997; 8: 327-335.
12. Malm J, Laurel! M, Dahlbäck B. Changes in the plasma levels of vitamin Independent proteins C and S and C4bbinding protein during pregnancy and oral contraception. Br J Haematol 1988; 68: 437-443.
13. Boerger LM. Morris PC. Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987; 69: 692-694.
14. Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997; 78: 315-326.
15. Eafeuillade A, Alessi MC, Poizot-Martin I, et al. Protein S deficiency and HIV infection. N Engl J Med 1991; 324, 1220.
16. Rosen S. Johansson K. Eindberg B, Dahlbäck B. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. Thromb Haemost 1994; 72: 255-260.
17. Martinoli JE, Stocker K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986; 43: 253-264.
18. Amiral J, Grosley M, Boyer-Neumann C. et al: New direct assay for free protein S antigen using two distinct monoclonal antibodies specific for the free form. Blood Coag Fibrinolysis 1994; 5: 179-186.
19. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg-Gin mutation. Blood Coag Fibrinolysis 1995; 6: 245-248.